Expression of cyclooxygenase-2 and its relationship with mismatch repair and microsatellite instability in hereditary nonpolyposis colorectal cancer

Chinese Medical Sciences Journal

Volumn 25, Issue 4, 2010, Pages 206-210

  Jin, Peng ^a   Sheng, Jian Qiu ^a   Zhang, Ying Hui ^a   Li, Ai Qin ^a   Wu, Zi Tao ^a   Li, Shi Rong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Colorectal cancer; Cyclooxygenase 2; Hereditary nonpolyposis colorectal cancer; Microsatellite instability; Mismatch repair

Indexed keywords

CYCLOOXYGENASE 2; MISMATCH REPAIR PROTEIN;

ARTICLE; CLINICAL ARTICLE; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MICROSATELLITE INSTABILITY; PROTEIN EXPRESSION;

EID: 79952796082     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1001-9294(11)60003-5     Document Type: Article

References (14)

1. Bonis PA, Trikalinos TA, Chung M, et al. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications. Evid Rep Technol Assess (Full Rep) 2007; 150:1-180.
2. Zhang L. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing. J Mol Diagn 2008; 10:301-7. (Pubitemid 352019114)
3. Oba M, Miwa K, Fujimura T, et al. Chemoprevention of glandular stomach carcinogenesis through duodenogastric reflux in rats by a COX-2 inhibitor. Int J Cancer 2008; 123:1491-8.
4. Bresalier RS. Chemoprevention of colorectal neoplasia: advances and controversies (the COX-2 story). Curr Opin Gastroenterology 2007; 23:44-7. (Pubitemid 44875909)
5. Chew MH, Koh PK, Ng KH, et al. Phenotypic characteristics of hereditary non-polyposis colorectal cancer by the Amsterdam criteria: an Asian perspective. ANZ J Surg 2008; 78:556-60.
6. Vasen HF, Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116:1453-6. (Pubitemid 29258894)
7. Sheng JQ, Chan TL, Chan YW, et al. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer. Chin J Dig Dis 2006; 7:197-205.
8. Lim SC, Lee TB, Choi CH, et al. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in colorectal cancers. Yonsei Med J 2007; 48:495-501.
9. Ferrario A, Fisher AM, Rucker N, et al. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res 2005; 65:9473-8. (Pubitemid 41508016)
10. Yim HW, Jong HS, Kim TY, et al. Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosis. Cancer Res 2005; 65:1952-60.
11. Brown JR, DuBois RN. COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol 2005; 23:2840-55. (Pubitemid 46179475)
12. Sheng JQ, Li SR, Yang XY, et al. Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis. Zhonghua Yi Xue Za Zhi 2006; 86:526-9.
13. Karnes WE Jr, Shattuck-Brandt R, Burgart LJ, et al. Reduced COX-2 protein in colorectal cancer with defective mismatch repair. Cancer Res 1998; 58:5473-7. (Pubitemid 28551132)
14. Song WQ, Han CL, Zhou BJ, et al. Relationship between COX-2 expression and hMLH1, hMSH2 expression in colorectal carcinoma. World Chin J Digestol 2005; 13:105-9.